2020 American Transplant Congress
Multiplicity of Non-HLA Targets for Antibodies Developed in Association with Ventricular Assist Device Implantation
Baylor University Medical Center and Baylor Scott & White Research Institute, Dallas, TX
*Purpose: Multiple non-HLA antibodies have been implicated in poor outcomes after heart transplantation. Development of HLA and Non-HLA antibodies have been reported in association with…2020 American Transplant Congress
Possible Mechanism of Sensitization against Angiotensin Type II Receptor after LVAD Implantation
1Surgery, VCUHS, Richmond, VA, 2Cardiology, VCUHS, Richmond, VA
*Purpose: Detection of antibody (Ab) against angiotensin-II receptor (AT1R) following VAD implantation portends poorer outcomes for heart transplantation (HT). However, the cause of this sensitization…2020 American Transplant Congress
Effect of Intravenous Ferric Gluconate on Post Heart Transplant Outcomes in Patients Bridged with Left Ventricular Assist Devices
Internal Medicine, Loyola University Medical Center, Maywood, IL
*Purpose: Our study examined the effect of intravenous (IV) ferric gluconate compared to oral iron repletion in reducing 30-day hospital readmissions and all-cause mortality in…2020 American Transplant Congress
Management and Outcomes of Heart Transplant Recipients with Pre-Transplant Left Ventricular Assist Device Infections
Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, MN
*Purpose: Infection involving Left Ventricular Assist Device (LVAD) in patients who receive device therapy as a bridge to heart transplantation (HT) is a serious complication.…2020 American Transplant Congress
Characteristics and Outcomes of Patients with Cystic Fibrosis Receiving Lung Transplant with and without ECMO Bridge – A Single Center Experience
Pulmonary & Critical Care, USC, Los Angeles, CA
*Purpose: ECMO is a viable bridge to lung transplantation (LTx) for end-stage cystic fibrosis (CF) patients refractory to traditional medical support. We sought to identify…2019 American Transplant Congress
Efficacy of Long-Acting Octreotide in Left Ventricular Assist Device Patients with Recurrent Gastrointestinal Bleeding
*Purpose: Continuous flow ventricular assist device (VAD) patients have a high risk of recurrent gastrointestinal bleeding, often leading to readmission and morbidity. Intramuscular long-acting octreotide…2018 American Transplant Congress
Urinary Cell Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury Following Advanced Cardiac Replacement Therapies
Baylor University Medical Center, Dallas, TX.
Background: Current strategies to detect acute kidney injury (AKI) after cardiothoracic surgery rely on elevations in serum creatinine and diminished urine output, which are insensitive…2018 American Transplant Congress
Left Ventricular Assist Devices Complicated by Gastrointestinal Bleeding and Outcomes on Transplant
Internal Medicine, Cardiac Surgery, Cardiology, Henry Ford Hospital, Detroit.
Left Ventricular Assist Devices (LVAD) are becoming the standard of care in advanced heart failure patients. However, despite ongoing advances in this technology, there remains…2018 American Transplant Congress
Timing of Infections after Total Artificial Heart Implantation. What Did We Learn?
Transplant Infectious Diseases, University of Nebraska Medical Center, Omaha, NE.
Background: The total artificial heart (TAH) has become a reliable bridge to heart transplantation. There are no studies describing the timing of infections post-TAH implantation.…2017 American Transplant Congress
Improved Creatinine Immediately Post-LVAD Predicts Lower AKI Risk After Heart Transplant.
Background-Left ventricular assist device(LVAD) placement often improves renal function in patients with advanced heart failure. In those bridged to transplant with LVAD support it is…
American Transplant Congress abstracts